|
1
|
Kirk B, Zanker J and Duque G:
Osteosarcopenia: Epidemiology, diagnosis and treatment-facts and
numbers. J Cachexia Sarcopenia Muscle. 11:609–618. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Li GH, Cheung CL, Tan KC, Kung AW, Kwok
TC, Lau WC, Wong JS, Hsu WWQ, Fang C and Wong IC: Development and
validation of sex-specific hip fracture prediction models using
electronic health records: a retrospective, population-based cohort
study. EClinicalMedicine. 58(101876)2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Yuan S and Larsson SC: Epidemiology of
sarcopenia: Prevalence, risk factors and consequences. Metabolism.
144(155533)2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Shimada H, Suzuki T, Doi T, Lee S,
Nakakubo S, Makino K and Arai H: Impact of osteosarcopenia on
disability and mortality among Japanese older adults. J Cachexia
Sarcopenia Muscle. 14:1107–1116. 2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Locquet M, Beaudart C, Reginster JY and
Bruyère O: Association between the decline in muscle health and the
decline in bone health in older individuals from the SarcoPhAge
cohort. Calcif Tissue Int. 104:273–284. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Clynes MA, Gregson CL, Bruyère O, Cooper C
and Dennison EM: Osteosarcopenia: where osteoporosis and sarcopenia
collide. Rheumatology (Oxford). 60:529–537. 2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Inoue T, Maeda K, Nagano A, Shimizu A,
Ueshima J, Murotani K, Sato K, Hotta K, Morishita S and Tsubaki A:
Related factors and clinical outcomes of osteosarcopenia: A
narrative review. Nutrients. 13(291)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Prockop DJ: Marrow stromal cells as stem
cells for nonhematopoietic tissues. Science. 276:71–74.
1997.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Loh KM, Chen A, Koh PW, Deng TZ, Sinha R,
Tsai JM, Barkal AA, Shen KY, Jain R, Morganti RM, et al: Mapping
the pairwise choices leading from pluripotency to human bone, heart
and other mesoderm cell types. Cell. 166:451–467. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yin L, Yang Z, Wu Y, Denslin V, Yu CC, Tee
CA, Lim CT, Han J and Lee EH: Label-free separation of mesenchymal
stem cell subpopulations with distinct differentiation potencies
and paracrine effects. Biomaterials. 240(119881)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Feng Z, Jin M, Liang J, Kang J, Yang H,
Guo S and Sun X: Insight into the effect of biomaterials on
osteogenic differentiation of mesenchymal stem cells: A review from
a mitochondrial perspective. Acta Biomater. 164:1–14.
2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shivdasani RA: MicroRNAs: Regulators of
gene expression and cell differentiation. Blood. 108:3646–3653.
2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang E: MicroRNA, the putative molecular
control for mid-life decline. Ageing Res Rev. 6:1–11.
2007.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sun Y, Kuek V, Liu Y, Tickner J, Yuan Y,
Chen L, Zeng Z, Shao M, He W and Xu J: MiR-214 is an important
regulator of the musculoskeletal metabolism and disease. J Cell
Physiol. 234:231–245. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Fariyike B, Singleton Q, Hunter M, Hill
WD, Isales CM, Hamrick MW and Fulzele S: Role of MicroRNA-141 in
the aging musculoskeletal system: A current overview. Mech Ageing
Dev. 178:9–15. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Shang Q, Shen G, Chen G, Zhang Z, Yu X,
Zhao W, Zhang P, Chen H, Tang K, Yu F, et al: The emerging role of
miR-128 in musculoskeletal diseases. J Cell Physiol. 236:4231–4243.
2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sun D, Chen Y, Liu X, Huang G, Cheng G, Yu
C and Fang J: miR-34a-5p facilitates osteogenic differentiation of
bone marrow mesenchymal stem cells and modulates bone metabolism by
targeting HDAC1 and promoting ER-α transcription. Connect Tissue
Res. 64:126–138. 2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang C, Zhu M, Yang D, Hu X, Wen X and Liu
A: MiR-29a-3p inhibits proliferation and osteogenic differentiation
of human bone marrow mesenchymal stem cells via targeting FOXO3 and
repressing Wnt/β-catenin signaling in steroid-associated
osteonecrosis. Int J Stem Cells. 15:324–333. 2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang YC, Yao X, Ma M, Zhang H, Wang H,
Zhao L, Liu S, Sun C, Li P, Wu Y, et al: miR-130b inhibits
proliferation and promotes differentiation in myocytes via
targeting Sp1. J Mol Cell Biol. 13:422–432. 2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yang L, Qi Q, Wang J, Song C, Wang Y, Chen
X, Chen H, Zhang C, Hu L and Fang X: MiR-452 regulates C2C12
myoblast proliferation and differentiation via targeting
ANGPT1. Front Genet. 12(640807)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
van Rooij E, Liu N and Olson EN: MicroRNAs
flex their muscles. Trends Genet. 24:159–166. 2008.PubMed/NCBI View Article : Google Scholar
|
|
22
|
U.S. Office of Science and Technology
Policy. Laboratory animal welfare; U.S. government principles for
the utilization and care of vertebrate animals used in testing,
research and training; notice. Fed Regist. 50:20864–20865.
1985.PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Townley-Tilson WH, Callis TE and Wang D:
MicroRNAs 1, 133 and 206: critical factors of skeletal and cardiac
muscle development, function and disease. Int J Biochem Cell Biol.
42:1252–1255. 2010.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Walden TB, Timmons JA, Keller P,
Nedergaard J and Cannon B: Distinct expression of muscle-specific
microRNAs (myomirs) in brown adipocytes. J Cell Physiol.
218:444–449. 2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wu K, Li J, Qi Y, Zhang C, Zhu D, Liu D
and Zhao S: SNHG14 confers gefitinib resistance in non-small cell
lung cancer by up-regulating ABCB1 via sponging miR-206-3p. Biomed
Pharmacother. 116(108995)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kular J, Tickner J, Chim SM and Xu J: An
overview of the regulation of bone remodelling at the cellular
level. Clin Biochem. 45:863–873. 2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Guo S, Gu J, Ma J, Xu R, Wu Q, Meng L, Liu
H, Li L and Xu Y: GATA4-driven miR-206-3p signatures control
orofacial bone development by regulating osteogenic and
osteoclastic activity. Theranostics. 11:8379–8395. 2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang B, Yu P, Li T, Bian Y and Weng X:
MicroRNA expression in bone marrow mesenchymal stem cells from mice
with steroid-induced osteonecrosis of the femoral head. Mol Med
Rep. 12:7447–7454. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Li H, Zhai Z, Qu X, Xu J, Qin A and Dai K:
MicroRNAs as potential targets for treatment of osteoclast-related
diseases. Curr Drug Targets. 19:422–431. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li D, Liu J, Guo B, Liang C, Dang L, Lu C,
He X, Cheung HY, Xu L, Lu C, et al: Osteoclast-derived exosomal
miR-214-3p inhibits osteoblastic bone formation. Nat Commun.
7(10872)2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Tagliaferri C, Wittrant Y, Davicco MJ,
Walrand S and Coxam V: Muscle and bone, two interconnected tissues.
Ageing Res Rev. 21:55–70. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Bakker AD and Jaspers RT: IL-6 and IGF-1
signaling within and between muscle and bone: How important is the
mTOR pathway for bone metabolism? Curr Osteoporos Rep. 13:131–139.
2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
van Loon K, Huijbers EJM and Griffioen AW:
Secreted frizzled-related protein 2: A key player in noncanonical
Wnt signaling and tumor angiogenesis. Cancer Metastasis Rev.
40:191–203. 2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Bodine PVN, Seestaller-Wehr L, Kharode YP,
Bex FJ and Komm BS: Bone anabolic effects of parathyroid hormone
are blunted by deletion of the Wnt antagonist secreted
frizzled-related protein-1. J Cell Physiol. 210:352–357.
2007.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Descamps S, Arzouk H, Bacou F, Bernardi H,
Fedon Y, Gay S, Reyne Y, Rossano B and Levin J: Inhibition of
myoblast differentiation by Sfrp1 and Sfrp2. Cell Tissue Res.
332:299–306. 2008.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Yang Y, Sun W, Wang R, Lei C, Zhou R, Tang
Z and Li K: Wnt antagonist, secreted frizzled-related protein 1, is
involved in prenatal skeletal muscle development and is a target of
miRNA-1/206 in pigs. BMC Mol Biol. 16(4)2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Jiang P, Wei K, Chang C, Zhao J, Zhang R,
Xu L, Jin Y, Xu L, Shi Y, Guo S, et al: SFRP1 negatively modulates
pyroptosis of fibroblast-like synoviocytes in rheumatoid arthritis:
A review. front immunol. 13(903475)2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Bodine PVN and Komm BS: Wnt signaling and
osteoblastogenesis. Rev Endocr Metab Disord. 7:33–39.
2006.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Yang YJ and Kim DJ: An overview of the
molecular mechanisms contributing to musculoskeletal disorders in
chronic liver disease: Osteoporosis, sarcopenia and osteoporotic
sarcopenia. Int J Mol Sci. 22(2604)2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Cossu G and Borello U: Wnt signaling and
the activation of myogenesis in mammals. EMBO J. 18:6867–6872.
1999.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Hoeppner LH, Secreto FJ and Westendorf JJ:
Wnt signaling as a therapeutic target for bone diseases. Expert
Opin Ther Targets. 13:485–496. 2009.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Boudin E, Fijalkowski I, Piters E and Van
Hul W: The role of extracellular modulators of canonical Wnt
signaling in bone metabolism and diseases. Semin Arthritis Rheum.
43:220–240. 2013.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Law SM and Zheng JJ: Premise and peril of
Wnt signaling activation through GSK-3β inhibition. iScience.
25(104159)2022.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Shevtsov SP, Haq S and Force T: Activation
of beta-catenin signaling pathways by classical G-protein-coupled
receptors: Mechanisms and consequences in cycling and non-cycling
cells. Cell Cycle. 5:2295–2300. 2006.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Yılmaz D, Mathavan N, Wehrle E, Kuhn GA
and Müller R: Mouse models of accelerated aging in musculoskeletal
research for assessing frailty, sarcopenia and osteoporosis-A
review. Ageing Res Rev. 93(102118)2024.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Zhang N, Chow SKH, Leung KS, Lee HH and
Cheung WH: An animal model of co-existing sarcopenia and
osteoporotic fracture in senescence accelerated mouse prone 8
(SAMP8). Exp Gerontol. 97:1–8. 2017.PubMed/NCBI View Article : Google Scholar
|
